vs

Side-by-side financial comparison of PAR TECHNOLOGY CORP (PAR) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $120.1M, roughly 1.3× PAR TECHNOLOGY CORP). On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 14.4%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-12.5M).

PAR Technology Corp is a global provider of point-of-sale systems, restaurant management software, and integrated tech solutions. Its core segments serve food service, hospitality, and government security markets, offering cloud tools to streamline operations, enhance customer experiences, and boost efficiency for enterprise and small-to-medium clients.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

PAR vs STOK — Head-to-Head

Bigger by revenue
STOK
STOK
1.3× larger
STOK
$158.6M
$120.1M
PAR
Growing faster (revenue YoY)
STOK
STOK
+3646.7% gap
STOK
3661.1%
14.4%
PAR
More free cash flow
STOK
STOK
$144.2M more FCF
STOK
$131.7M
$-12.5M
PAR

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
PAR
PAR
STOK
STOK
Revenue
$120.1M
$158.6M
Net Profit
$112.9M
Gross Margin
41.2%
Operating Margin
-15.0%
70.2%
Net Margin
71.2%
Revenue YoY
14.4%
3661.1%
Net Profit YoY
528.0%
EPS (diluted)
$-0.52
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PAR
PAR
STOK
STOK
Q4 25
$120.1M
Q3 25
$119.2M
Q2 25
$112.4M
Q1 25
$103.9M
$158.6M
Q4 24
$105.0M
$22.6M
Q3 24
$96.8M
Q2 24
$78.2M
Q1 24
$70.1M
Net Profit
PAR
PAR
STOK
STOK
Q4 25
Q3 25
$-18.2M
Q2 25
$-21.0M
Q1 25
$-24.4M
$112.9M
Q4 24
$-10.5M
Q3 24
$-19.8M
Q2 24
$54.2M
Q1 24
$-18.3M
Gross Margin
PAR
PAR
STOK
STOK
Q4 25
41.2%
Q3 25
41.3%
Q2 25
45.4%
Q1 25
46.5%
Q4 24
42.9%
Q3 24
44.5%
Q2 24
41.0%
Q1 24
37.2%
Operating Margin
PAR
PAR
STOK
STOK
Q4 25
-15.0%
Q3 25
-14.8%
Q2 25
-15.4%
Q1 25
-15.2%
70.2%
Q4 24
-15.6%
-60.4%
Q3 24
-15.7%
Q2 24
-26.5%
Q1 24
-38.2%
Net Margin
PAR
PAR
STOK
STOK
Q4 25
Q3 25
-15.3%
Q2 25
-18.7%
Q1 25
-23.4%
71.2%
Q4 24
-46.4%
Q3 24
-20.5%
Q2 24
69.3%
Q1 24
-26.1%
EPS (diluted)
PAR
PAR
STOK
STOK
Q4 25
$-0.52
Q3 25
$-0.45
Q2 25
$-0.52
Q1 25
$-0.60
$1.90
Q4 24
$-0.56
$-0.15
Q3 24
$-0.56
Q2 24
$1.60
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PAR
PAR
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$80.1M
$274.8M
Total DebtLower is stronger
$394.0M
Stockholders' EquityBook value
$825.1M
$350.1M
Total Assets
$1.4B
$406.9M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PAR
PAR
STOK
STOK
Q4 25
$80.1M
Q3 25
$93.0M
Q2 25
$85.7M
Q1 25
$92.2M
$274.8M
Q4 24
$108.6M
$128.0M
Q3 24
$118.4M
Q2 24
$142.5M
Q1 24
$72.5M
Total Debt
PAR
PAR
STOK
STOK
Q4 25
$394.0M
Q3 25
$393.4M
Q2 25
$392.8M
Q1 25
$392.3M
Q4 24
$368.4M
Q3 24
$466.7M
Q2 24
$378.7M
Q1 24
$378.2M
Stockholders' Equity
PAR
PAR
STOK
STOK
Q4 25
$825.1M
Q3 25
$838.0M
Q2 25
$859.1M
Q1 25
$852.0M
$350.1M
Q4 24
$871.7M
$229.0M
Q3 24
$692.7M
Q2 24
$588.3M
Q1 24
$526.4M
Total Assets
PAR
PAR
STOK
STOK
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
$1.4B
$406.9M
Q4 24
$1.4B
$271.6M
Q3 24
$1.3B
Q2 24
$1.1B
Q1 24
$1.0B
Debt / Equity
PAR
PAR
STOK
STOK
Q4 25
0.48×
Q3 25
0.47×
Q2 25
0.46×
Q1 25
0.46×
Q4 24
0.42×
Q3 24
0.67×
Q2 24
0.64×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PAR
PAR
STOK
STOK
Operating Cash FlowLast quarter
$-11.8M
$131.8M
Free Cash FlowOCF − Capex
$-12.5M
$131.7M
FCF MarginFCF / Revenue
-10.4%
83.0%
Capex IntensityCapex / Revenue
0.7%
0.1%
Cash ConversionOCF / Net Profit
1.17×
TTM Free Cash FlowTrailing 4 quarters
$-30.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PAR
PAR
STOK
STOK
Q4 25
$-11.8M
Q3 25
$8.4M
Q2 25
$-6.6M
Q1 25
$-17.2M
$131.8M
Q4 24
$3.4M
$-23.2M
Q3 24
$8.8M
Q2 24
$-13.8M
Q1 24
$-23.6M
Free Cash Flow
PAR
PAR
STOK
STOK
Q4 25
$-12.5M
Q3 25
$7.0M
Q2 25
$-7.4M
Q1 25
$-17.6M
$131.7M
Q4 24
$3.2M
$-23.2M
Q3 24
$8.4M
Q2 24
$-14.2M
Q1 24
$-23.6M
FCF Margin
PAR
PAR
STOK
STOK
Q4 25
-10.4%
Q3 25
5.9%
Q2 25
-6.6%
Q1 25
-16.9%
83.0%
Q4 24
3.0%
-102.7%
Q3 24
8.7%
Q2 24
-18.2%
Q1 24
-33.7%
Capex Intensity
PAR
PAR
STOK
STOK
Q4 25
0.7%
Q3 25
1.1%
Q2 25
0.7%
Q1 25
0.4%
0.1%
Q4 24
0.2%
0.2%
Q3 24
0.4%
Q2 24
0.5%
Q1 24
0.1%
Cash Conversion
PAR
PAR
STOK
STOK
Q4 25
Q3 25
Q2 25
Q1 25
1.17×
Q4 24
Q3 24
Q2 24
-0.26×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PAR
PAR

Subscription Service$76.1M63%
Hardware$27.8M23%
Professional Service$16.2M13%

STOK
STOK

Segment breakdown not available.

Related Comparisons